These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35151685)

  • 1. Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation.
    Byts N; Sharma S; Malm T; Kaakinen M; Korhonen P; Jaakkonen L; Keuters M; Huuskonen M; Pietilä I; Koistinaho J; Koivunen P; Myllyharju J
    J Biol Chem; 2022 Mar; 298(3):101721. PubMed ID: 35151685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.
    Koivunen P; Serpi R; Dimova EY
    Pharmacol Res; 2016 Dec; 114():265-273. PubMed ID: 27832958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury.
    Hyvärinen J; Hassinen IE; Sormunen R; Mäki JM; Kivirikko KI; Koivunen P; Myllyharju J
    J Biol Chem; 2010 Apr; 285(18):13646-57. PubMed ID: 20185832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of P4H-TM in mice results in age-related retinal and renal alterations.
    Leinonen H; Rossi M; Salo AM; Tiainen P; Hyvärinen J; Pitkänen M; Sormunen R; Miinalainen I; Zhang C; Soininen R; Kivirikko KI; Koskelainen A; Tanila H; Myllyharju J; Koivunen P
    Hum Mol Genet; 2016 Sep; 25(17):3810-3823. PubMed ID: 27466183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis.
    Laitala A; Aro E; Walkinshaw G; Mäki JM; Rossi M; Heikkilä M; Savolainen ER; Arend M; Kivirikko KI; Koivunen P; Myllyharju J
    Blood; 2012 Oct; 120(16):3336-44. PubMed ID: 22955912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha.
    Koivunen P; Tiainen P; Hyvärinen J; Williams KE; Sormunen R; Klaus SJ; Kivirikko KI; Myllyharju J
    J Biol Chem; 2007 Oct; 282(42):30544-52. PubMed ID: 17726031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1 (HIF-1) but not HIF-2 is essential for hypoxic induction of collagen prolyl 4-hydroxylases in primary newborn mouse epiphyseal growth plate chondrocytes.
    Aro E; Khatri R; Gerard-O'Riley R; Mangiavini L; Myllyharju J; Schipani E
    J Biol Chem; 2012 Oct; 287(44):37134-44. PubMed ID: 22930750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury.
    Karsikas S; Myllymäki M; Heikkilä M; Sormunen R; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    J Mol Med (Berl); 2016 Mar; 94(3):301-10. PubMed ID: 26452676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of a transmembrane prolyl 4-hydroxylase in the zebrafish leads to basement membrane defects and compromised kidney function.
    Hyvärinen J; Parikka M; Sormunen R; Rämet M; Tryggvason K; Kivirikko KI; Myllyharju J; Koivunen P
    J Biol Chem; 2010 Dec; 285(53):42023-32. PubMed ID: 20952382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits.
    Zhou J; Li J; Rosenbaum DM; Zhuang J; Poon C; Qin P; Rivera K; Lepore J; Willette RN; Hu E; Barone FC
    PLoS One; 2017; 12(9):e0184049. PubMed ID: 28880966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmembrane Prolyl 4-Hydroxylase is a Novel Regulator of Calcium Signaling in Astrocytes.
    Byts N; Sharma S; Laurila J; Paudel P; Miinalainen I; Ronkainen VP; Hinttala R; Törnquist K; Koivunen P; Myllyharju J
    eNeuro; 2021; 8(1):. PubMed ID: 33298456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease.
    Laitakari A; Ollonen T; Kietzmann T; Walkinshaw G; Mennerich D; Izzi V; Haapasaari KM; Myllyharju J; Serpi R; Dimova EY; Koivunen P
    Redox Biol; 2019 Apr; 22():101145. PubMed ID: 30802717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
    Chen RL; Ogunshola OO; Yeoh KK; Jani A; Papadakis M; Nagel S; Schofield CJ; Buchan AM
    J Neurochem; 2014 Oct; 131(2):177-89. PubMed ID: 24974727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.
    Kerkelä R; Karsikas S; Szabo Z; Serpi R; Magga J; Gao E; Alitalo K; Anisimov A; Sormunen R; Pietilä I; Vainio L; Koch WJ; Kivirikko KI; Myllyharju J; Koivunen P
    Mol Cell Biol; 2013 Aug; 33(16):3321-9. PubMed ID: 23775121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Null mutation in P4h-tm leads to decreased fear and anxiety and increased social behavior in mice.
    Leinonen H; Koivisto H; Lipponen HR; Matilainen A; Salo AM; Dimova EY; Hämäläinen E; Stavén S; Miettinen P; Myllyharju J; Koivunen P; Tanila H
    Neuropharmacology; 2019 Jul; 153():63-72. PubMed ID: 31029587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism.
    Tapio J; Halmetoja R; Dimova EY; Mäki JM; Laitala A; Walkinshaw G; Myllyharju J; Serpi R; Koivunen P
    J Biol Chem; 2022 Aug; 298(8):102222. PubMed ID: 35787374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic characteristics of transmembrane prolyl 4-hydroxylase (P4H-TM) deficient mice.
    Ala-Nisula T; Halmetoja R; Leinonen H; Kurkela M; Lipponen HR; Sakko S; Karpale M; Salo AM; Sissala N; Röning T; Raza GS; Mäkelä KA; Thevenot J; Herzig KH; Serpi R; Myllyharju J; Tanila H; Koivunen P; Dimova EY
    Pflugers Arch; 2024 Sep; 476(9):1339-1351. PubMed ID: 38396259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
    Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X
    Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
    Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
    Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system.
    Siddiq A; Ayoub IA; Chavez JC; Aminova L; Shah S; LaManna JC; Patton SM; Connor JR; Cherny RA; Volitakis I; Bush AI; Langsetmo I; Seeley T; Gunzler V; Ratan RR
    J Biol Chem; 2005 Dec; 280(50):41732-43. PubMed ID: 16227210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.